ÌÇÄò²¡×ã/»¤Àí,diabetic foot /nursingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õþ¸®¾ÈÖú,government succorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØƤÏÂ×¢Éä,Multipe subcutaneous insulin infectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Ê²Ý¼å¼Á,liquorice decoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äò¦Á1-΢Çòµ°°×,Urine ¦Á1-microglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ŵºÍ±Ê,Nohe PenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºóÄÒÏ»ì×Ç,posterior subcapsular opacitiesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶¯Ì¬ÑªÌÇ,dynamic glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡´óѪ¹Ü²¢·¢Ö¢,Macrovascular DiseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 2ÐÍ/²¡ÀíÉúÀíѧ,type 2/physiopathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔçÆÚ¸ÉÔ¤ÖÎÁÆ,Early intervening treatmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÖ¬´úлÒì³£,Disorder of Glucolipide MetabolismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍâÀ´»é¼ÞÅ®,non-native married femaleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ·ÖÃÚϵͳ¼²²¡,endocrine system diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÖÊÊèËÉÖ¢/²¢·¢Ö¢,Osteoporosis/ complicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¬ÐøÐÔ½¡¿µ½ÌÓý,continuous health educationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÕÄ©ÆÚÌÇÄò²¡Éö²¡,End-stage diabetic nephropathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾«µ°°×ÒȵºËØ,Human NPH insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÀÅÁ˾ËûƬ,Epalrestat tabletÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßÌǵÍÖ¬ÉÅʳ,high-carbohydrate/low-fat dietÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡Òò·ÖÐÍ,Pathogeny typesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö«Ì幦Äָܻ´,restoration of limb functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³õÖÎ,de novoÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °×ϸ°û½éËØ16,interleukin-16Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖкÍÄÜÁ¦,neutralization abilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àëĸõòüºÏÎï,Polypeptide chromium chelateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢´´È«÷ŹؽÚÖû»Êõ,minimally invasive total hip arthroplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©ÎïµÄ°²È«ÐÔ,Security of MedicalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÖÊÊèËÉÐÔÐØÑü×µ¹ÇÕÛ,osteoporotic thoracolumbar fractureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Â2΢Çòµ°°×/Äò,beta 2-Microglobulin/urineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ŵºÍÁé50R,Novolin 50RÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ëæ»ú˫äƽÐжÔÕÕ,Randomized double-blind parallel controlÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×㲿»¤Àí,feet careÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡×ÔÎÒ¹ÜÀí,Seflf-management training on diabetesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÷¾¹Ç¶¤,sacroiliac screwsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« F1µ¥¿Ë¡¿¹Ìå,Monoclonal antibody against Fl Antigen of Y.pestisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÏ໥×÷ÓÃ,cell-cell interactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢Á¿°×µ°°×/¼¡ôû±ÈÖµ,ratio of microalbumin and creatinineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡ÍªÖ¢ËáÖж¾/Õï¶Ï,diabetic ketoacidosis/DIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ͼ±×µ¹ÇÕÛÍÑλ,subaxial cervical fracture-dislocationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÖÊõºó¸´·¢,Prolapse of Lumbar Intervertebral DiscÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ßäßòÀà/ÖÎÁÆÓ¦ÓÃ,Imidazoles/theraputic useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȸßÌÇËØÑù¶àëÄ-1,glucagon-like peptide-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÑÉï/ÉÅʳÁÆ·¨,gestational/diet therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡Éñ¾­²¡±ä/Õï¶Ï,Diabetic neuropathy/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÜΧÉñ¾­ËɽâÊõ,diabetic peripheral neuropathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂåÆÖ,Luopu CountyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐŦÄܼì²â,Measuremem of hean functionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÊÅÖÖ¢´óÊó,fat ratsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äò°×µ°°×/¼¡ôû±ÈÖµ,urinary albumin to creatinine ratioÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇƤÖʼ¤ËØÀà/¸±×÷ÓÃ,Glucocorticoids/adverse effectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙ¼²²¡/²¢·¢Ö¢,Pancreatic Diseases/complÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡ÐÔÏÂ֫ȱѪ,Diabetic lower limb ischemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Çŵ±´ÌؽºÄÒ,Lipantil capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇËè΢Ѫ¹ÜÃܶÈ,bone marrow microvessel densityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« IMBģʽ,IMB modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Áé֥Ƭ,glossy ganoderma pillsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 1-3-¦Â-D-ÆϾÛÌÇ,1-3-¦Â-D glucanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« άÉúËØB12/ÀàËÆÎïºÍÑÜÉúÎï,Vitamin B12/analogs &derivativesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹¼××´ÏÙÒ©/ÖÎÁÆÓ¦ÓÃ,Antithyroid agents/ therapeutic useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆÏÌÑÌǵ÷½ÚÒì³£,accommodation abnormality of glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬ÖØÂÊ,Overweight rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« èÛéÚËáĪɳ±ÈÀû·ÖɢƬ,Gastrophageal reflux diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßÉøÐÔ·Ç֢ͪ»èÃÔ,hyperosmolar nonketotic comaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸üÄêÆÚΧ¾ø¾­ÆÚ¸¾Å®,Menopause femaleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÕïÁƲÙ×÷,Operation of diagnosis and treatmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡»¼²¡ÂÊ,Rate of DMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¬Ðø¶¯Ì¬ÑªÌǼà²â,Continuous glucose monitoring system(CGMS)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« RNA¢óÒÖÖÆëÄ,RNA¢ó-inhibiting peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äò΢Á¿°×µ°°×(MAU),Micro-albumin urineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇòÄÒ³ÉÐÎ,expanding plastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿Õ³¦Æ½»¬¼¡,Jejunal smooth muscleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪҺÄæÁ÷,Blood back flowÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦ÊȸõÑùϸ°û,enterochromaffin-like cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÖÊÊèËÉ»¼²¡ÂÊ,prevalence rate of osteoporosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔ/Íâ¿Æѧ,primary surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍÙҺƤÖÊ´¼,Salivary cortisolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØ×ÔÉíÃâÒß×ÛºÏÕ÷,Insulin autoimmune syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ½á½Ú/Õï¶Ï,Thyroid nodule/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ëæ·Ã¹ÜÀí,Revisit Management of PatientsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³ÖÐøÐÔ¸ßѪÌÇ,Persistent hyperglycemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾«°±Ëá´Ì¼¤ÊÔÑé,Arginine stimulation testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CblÏà¹Øµ°°×,Cbl associated proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ¼²²¡/Õï¶Ï,thyroid diseases/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ°°×ÖÊÀÒ°±ËáÏõ»¯,protein tyrosine nitrationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« PKP,Percutaneous kyphoplasieÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« THµ°°×,calcium oxalateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ÷Ö¬ºÏ¼Á,Tiaozhi MisturaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²ÎÜνµÌǽºÄÒ,Shen qi jiang tang capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äòµ°°×µçÓ¾,proteinuria electrophroresisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÞëϸ°û,chorionic villus cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö¸¼âѪÌÇ,Fingertip blood glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à·¢¼Òϵ,Multigene familyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ˨ËØB2,6ͪ-Ç°ÁÐÏÙËØ,Thromboxane B2,6 ¨C keto ¨C ProstaglandinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´óÊóÉöÔà,rat kidneyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÉö×éÖ¯,hepatic and nephridial tissuesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Æ/Á×,Ca/P ratioÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöСÇòËðÉË,glomerular lesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʱ³½¸øÒ©,circadian time scheduleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÉãµâÂÊ,Radioactive iodine uptake rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 1 2 3 4 5 6 7 8 ÉÏÒ»Ò³